GB1908 is a selective oral inhibitor of galectin-1 (galectin-1), with Ki values of 57 nM for human galectin-1 and 72 nM for mouse galectin-1. It demonstrates over 50-fold selectivity for galectin-1 compared to galectin-3. GB1908 can be utilized in lung cancer research.
Formula:
C18H18Cl2N4O5S2
Target:
Galectin
* VAT and and shipping costs not included. Errors and price changes excepted